Aderans Research is pioneering what could end up being the most innovative treatment for baldness to come along in a century. Unlike most other companies researching male hair loss and women thinning hair, Aderans is concentrating on a technology that uses a patient’s own cells (known as autologous cells) to develop a virtually limitless amount of new hair follicles. This will obviously be a very expensive treatment for baldness because it will be, in a sense, customized for each patient.
Aderans calls the technology it is developing the Ji Gami™ process. Here’s how it works. Technicians remove a small piece of hair follicle tissue from a patient’s scalp, generally near the neckline. The hair follicle cells are then cultured in a laboratory so that they multiply. When a sufficient amount of new cells have been grown, the hair follicle cells — each unique to the individual patient — are then injected into the bald or thinning areas of the patient’s scalp.
Aderans executives believe they are on the verge of a true cure for baldness, a treatment for hair that will result in almost unlimited new hair growth. This approach is not the same as those attempting to use growth factor serums to regenerate existing dormant hair follicles. Instead, Aderans is attempting to grow new follicle cells, made from cells taken from the patient’s own scalp, and inject them into balding areas for hair growth.
How is the research proceeding? At the moment, Aderans is completing its Phase II clinical testing of its hair fall remedies. A total of more than 350 hair loss sufferers are now enrolled in the clinical trial from cities across the country. At the 2012 Winter Clinical Dermatology Conference in Maui in January, Aderans CEO Dr. Ken Washenik (M.D. & Ph.D.) presented a paper on “Emerging Therapies for Hair Loss” that received a standing ovation from the assembled dermatologists and hair restoration doctors. That’s because Dr. Washenik reported that the Clinical Trials of the Ji Gami™ process are going very well. While the process is not a magic pill that provides install hair like a Chia Pet, it does appear to grow new hair where none existed before — and, what’s more, can provide a virtually limitless supply of donor hair follicles for hair restoration doctors to use. In earlier tests, released in 2010, Aderans reported that more than half of participants in its clinical study showed “significant hair growth” one year after the cell product treatment was administered.
If you’d like to read more technical information about the early developments of this technology, then click on the link below for a PDF…
Bioengineering the Hair Follicle: Fringe Benefits of Stem Cell Technology
The Aderans “cell engineering” approach appears to be the most promising treatment for baldness on the horizon at the moment, according to the company’s spokesman, Vern Liebmann. That’s because the cell engineering approach offers hope for bald men who do not have enough donor hair for a cosmetically satisfying traditional hair transplant. With a limitless amount of donor hair follicles, the Aderans hair treatment could cover virtually any scalp with thick, natural hair.
If you’d like more information about Aderans and its clinical trials, fill in the form below:
- Hair Loss Products: RepliCel Life Sciences to Conduct Phase II Clinical Trials of its Hair Cell Replication Technology
- RepliCel Now Accepting Applications for Upcoming Clinical Trials of Hair Cloning Technology
- Update on Aderans on Hair Cloning Technology
- RepliCel Life Sciences Keeping the Dream of Hair Regeneration Alive
- Baldness Cure: Replicel Develops Hair Loss Treatment for Cue Ball Heads!